| Treatment persistence and healthcare costs among patients with rheumatoid arthritis changing biologics in the USA B Chastek, CI Chen, C Proudfoot, S Shinde, A Kuznik, W Wei Advances in Therapy 34, 2422-2435, 2017 | 42 | 2017 |
| Trends in HbA1c and body mass index among individuals with type 2 diabetes: evidence from a US database 2012–2019 KS Boye, MJ Lage, S Shinde, V Thieu, JP Bae Diabetes Therapy 12 (7), 2077-2087, 2021 | 33 | 2021 |
| Obesity and glycemic control among people with type 2 diabetes in the United States: a retrospective cohort study using insurance claims data KS Boye, MJ Lage, V Thieu, S Shinde, S Dhamija, JP Bae Journal of Diabetes and its Complications 35 (9), 107975, 2021 | 27 | 2021 |
| Treatment persistence and healthcare costs among patients with rheumatoid arthritis after a change in targeted therapy MMK Bonafede, D McMorrow, C Proudfoot, S Shinde, A Kuznik, CI Chen American Health & Drug Benefits 11 (4), 192, 2018 | 22 | 2018 |
| Pharmacogenomics: assessing educational exposure, confidence in knowledge and training elements of pharmacists KE Benzeroual, B Shah, S Shinde Personalized medicine 9 (4), 387-393, 2012 | 18 | 2012 |
| Antiobesity medication use among overweight and obese adults in the United States: 2015–2018 J MacEwan, H Kan, K Chiu, JL Poon, S Shinde, NN Ahmad Endocrine Practice 27 (11), 1139-1148, 2021 | 17 | 2021 |
| Weight change and the association with adherence and persistence to diabetes therapy: a narrative review KS Boye, S Shinde, T Kennedy-Martin, S Robinson, VT Thieu Patient preference and adherence, 23-39, 2022 | 12 | 2022 |
| The burden of type 2 diabetes and the value of achieving near normoglycemia from the patient perspective H Gelhorn, Z Balantac, S Shinde, VT Thieu, KS Boye Diabetes Therapy 12 (7), 1821-1837, 2021 | 9 | 2021 |
| Treprostinil: Safety Signal Detection Based on Adverse Event Reporting System Database S Shinde J. Pharmacovigil 2 (2), 2014 | 4 | 2014 |
| Clinical, economic, and health‐related quality of life outcomes in patients with overweight or obesity in the United States: 2016–2018 JP MacEwan, K Chiu, NN Ahmad, N Sacks, S Shinde, JL Poon, H Kan Obesity Science & Practice 10 (1), e726, 2024 | 2 | 2024 |
| The benefits of safely achieving near normoglycemia from the perspective of people with type 2 diabetes: a quantitative survey study HL Gelhorn, MM Ross, S Shinde, VT Thieu, KS Boye Patient preference and adherence, 1897-1906, 2022 | 2 | 2022 |
| The science of safety–an emerging concept in medication use and research S Shinde, SY Crawford INNOVATIONS in pharmacy 7 (3), 2016 | 2 | 2016 |
| Cost-Effectiveness Analysis of Ado-Trastuzumab Emtansine Compared to Lapatinib-Capecitabine Combination In Her2-Positive Metastatic Breast Cancer D Gor, W Lee, K Kim, A Mohan, K Peng, S Sarangpur, S Shinde, ... Value in Health 18 (3), A205, 2015 | 2 | 2015 |
| The roles of type 2 diabetes and obesity in disease activity and progression of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis S Shinde, DR Nelson, J Mitroi, PC Heaton, AL Hincapie, B Brouwers Current Medical Research and Opinion 40 (1), 59-68, 2024 | 1 | 2024 |
| 952-P: The Relationship between Weight Loss and HbA1c in People with Type 2 Diabetes S Shinde, V Thieu, A Kwan, KF Houghton, D Schapiro, J Meyers Diabetes 71 (Supplement_1), 2022 | 1 | 2022 |
| Anti-Obesity Medication Use in Commercially Insured Adults in the United States H Kan, N Sacks, K Chiu, S Shinde, JL Poon, N Ahmad OBESITY 28, 49-49, 2020 | 1 | 2020 |
| 56-PUB: Understanding the Patient Experience of Heart Failure with Preserved Ejection Fraction (HFpEF) and Obesity—Qualitative Insights from Patients and Clinicians C KANU, T AL-ZUBEIDI, S SHINDE, G AL-JASSAR, J LING POON, ... Diabetes 73 (Supplement_1), 2024 | | 2024 |
| Effect of Tirzepatide on Weight Reduction in People With Obstructive Sleep Apnea and Obesity: A Post Hoc Analysis of the SURMOUNT Trials B Falcon, A Malhotra, R Taylor, S Shinde, I Jouravskaya, J Dunn, ... A110. NEW FRONTIERS IN SLEEP APNEA DIAGNOSIS AND THERAPIES, A2990-A2990, 2024 | | 2024 |
| 0620 Effect of Tirzepatide on Weight Loss in Patients with Obstructive Sleep Apnea and Obesity from SURMOUNT-1 RR Grunstein, R Taylor, S Shinde, JP Dunn, J Bednarik, A Stefanski, ... Sleep 47 (Supplement_1), A264-A265, 2024 | | 2024 |
| Understanding the impact of non-alcoholic steatohepatitis with metabolic comorbidities on adults: a real-world qualitative study S Shinde, N Taylor, C Chinthammit, R Wilson, SM Burgess, JL Poon Current Medical Research and Opinion, 1-22, 2024 | | 2024 |
